Mark E. Borowsky

Oncology

19 Davis Avenue
Floor 7
Neptune, NJ 7753.

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer.

Extended Venous Thromboembolism Prophylaxis after Robotic Staging for Endometrial Cancer.

Journal: Southern medical journal

Published: October 03, 2023

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

Journal: Cancer

Published: September 20, 2023

Sex cord stromal tumor presenting with hair loss in postmenopausal women.

Sex cord stromal tumor presenting with hair loss in postmenopausal women.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: December 25, 2021

Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer.

Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer.

Journal: Southern medical journal

Published: November 03, 2021

NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.

NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.

Journal: Cancer research

Published: September 09, 2019

ARID1A promotes genomic stability through protecting telomere cohesion.

ARID1A promotes genomic stability through protecting telomere cohesion.

Journal: Nature communications

Published: April 25, 2019

EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.

EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.

Journal: Cancer cell

Published: January 28, 2019

CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer.

CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer.

Journal: Scientific reports

Published: April 30, 2018

Incidence of Endometrial Hyperplasia or Carcinoma at the Time of Endometrial Ablation.

Incidence of Endometrial Hyperplasia or Carcinoma at the Time of Endometrial Ablation.

Journal: Journal of minimally invasive gynecology

Published: September 29, 2016

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells.

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells.

Journal: Immunity

Published: August 02, 2016

Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.

Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.

Journal: Cell reports

Published: September 16, 2015

Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.

Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 03, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026